CN102459321A - 酪蛋白来源的蛋白酶抑制肽 - Google Patents

酪蛋白来源的蛋白酶抑制肽 Download PDF

Info

Publication number
CN102459321A
CN102459321A CN2010800351493A CN201080035149A CN102459321A CN 102459321 A CN102459321 A CN 102459321A CN 2010800351493 A CN2010800351493 A CN 2010800351493A CN 201080035149 A CN201080035149 A CN 201080035149A CN 102459321 A CN102459321 A CN 102459321A
Authority
CN
China
Prior art keywords
peptide
seq
casein
thr
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800351493A
Other languages
English (en)
Chinese (zh)
Inventor
埃里克·查尔斯·雷诺兹
斯图尔特·杰弗里·达斯弗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oral Health Australia Pty Ltd
Original Assignee
Oral Health Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009902841A external-priority patent/AU2009902841A0/en
Application filed by Oral Health Australia Pty Ltd filed Critical Oral Health Australia Pty Ltd
Publication of CN102459321A publication Critical patent/CN102459321A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN2010800351493A 2009-06-19 2010-06-18 酪蛋白来源的蛋白酶抑制肽 Pending CN102459321A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2009902841A AU2009902841A0 (en) 2009-06-19 Protease inhibitory peptides
AU2009902841 2009-06-19
PCT/AU2010/000760 WO2010144968A1 (en) 2009-06-19 2010-06-18 Casein derived protease inhibitory peptides

Publications (1)

Publication Number Publication Date
CN102459321A true CN102459321A (zh) 2012-05-16

Family

ID=43355610

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800351493A Pending CN102459321A (zh) 2009-06-19 2010-06-18 酪蛋白来源的蛋白酶抑制肽

Country Status (8)

Country Link
US (1) US20110104179A1 (enExample)
EP (2) EP2821414A1 (enExample)
JP (1) JP2012530073A (enExample)
KR (1) KR20120027535A (enExample)
CN (1) CN102459321A (enExample)
AU (1) AU2010262763A1 (enExample)
CA (1) CA2765423A1 (enExample)
WO (1) WO2010144968A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2652957A1 (en) 2006-06-27 2008-01-03 Oral Health Australia Pty Ltd. Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease
GB2463181B (en) 2007-05-14 2013-03-27 Univ New York State Res Found Induction of a physiological dispersion response in bacterial cells in a biofilm
EP2604692A1 (en) 2007-07-12 2013-06-19 Oral Health Australia Pty Ltd Immunology treatment for biofilms
CN103357014A (zh) * 2007-07-12 2013-10-23 口腔健康澳洲私人有限公司 生物膜治疗
US8140041B2 (en) * 2009-08-27 2012-03-20 Mediatek Inc. Tunable capacitive device with linearization technique employed therein
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
CN108840927B (zh) * 2018-06-06 2022-07-29 湖南生达生物科技有限公司 弹性蛋白酶抑制剂lnsp-i及其应用
WO2020167152A1 (en) * 2019-02-15 2020-08-20 RAPAK, Andrzej Marek Inhibitors of cysteine peptidases isolated from natural raw materials and use of the inhibitors in medicine and veterinary medicine
JP6797966B2 (ja) * 2019-04-24 2020-12-09 森永乳業株式会社 胃内酸性プロテアーゼ酵素活性阻害剤、ラクトフェリン組成物の製造方法、及びラクトフェリン組成物
CN113677316A (zh) * 2019-04-26 2021-11-19 高露洁-棕榄公司 用于减少抗菌口腔护理组合物染色的方法和组合物
US11013677B2 (en) 2019-04-26 2021-05-25 Colgate-Palmolive Company Methods and compositions to reduce staining for antibacterial oral care compositions
KR20220034563A (ko) * 2020-09-11 2022-03-18 한국생명공학연구원 신규 치주 질환 특이 항체 및 이의 용도
KR102476515B1 (ko) * 2020-09-11 2022-12-12 한국생명공학연구원 치주 질환 특이 항체 및 이의 용도
US20250334583A1 (en) * 2022-05-24 2025-10-30 Shimadzu Corporation Method for preparing sample solution containing neurogranin-related peptide and method for analyzing neurogranin-related peptide

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005058344A1 (en) * 2003-12-19 2005-06-30 The University Of Melbourne Antimicrobial composition
WO2005081628A2 (en) * 2004-03-01 2005-09-09 Peptera Pharmaceutical Ltd. Casein derived peptides and therapeutic uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698327A (en) * 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
JP3567012B2 (ja) * 1995-03-28 2004-09-15 雪印乳業株式会社 新規ペプチド及びその利用
AUPP051497A0 (en) * 1997-11-24 1997-12-18 University Of Melbourne, The Antimicrobial peptides
EP1359157A1 (en) * 2002-04-29 2003-11-05 Société des Produits Nestlé S.A. Metallo-proteinase inhibitory agent
CA2481489A1 (en) * 2002-11-29 2004-06-17 Morinaga Milk Industry Co., Ltd. Cysteine protease inhibitor
MY162557A (en) * 2010-02-26 2017-06-15 Oral Health Australia Pty Ltd Treatment or prevention of infection

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005058344A1 (en) * 2003-12-19 2005-06-30 The University Of Melbourne Antimicrobial composition
WO2005081628A2 (en) * 2004-03-01 2005-09-09 Peptera Pharmaceutical Ltd. Casein derived peptides and therapeutic uses thereof

Also Published As

Publication number Publication date
CA2765423A1 (en) 2010-12-23
KR20120027535A (ko) 2012-03-21
EP2443143A1 (en) 2012-04-25
JP2012530073A (ja) 2012-11-29
WO2010144968A1 (en) 2010-12-23
AU2010262763A1 (en) 2012-01-19
US20110104179A1 (en) 2011-05-05
EP2443143A4 (en) 2013-09-11
EP2821414A1 (en) 2015-01-07

Similar Documents

Publication Publication Date Title
CN102459321A (zh) 酪蛋白来源的蛋白酶抑制肽
AU2008274906B2 (en) Biofilm treatment
JP5615184B2 (ja) 皮膚病の治療におけるセリンプロテアーゼ阻害剤の使用
Li et al. Gingipains from Porphyromonas gingivalis—complex domain structures confer diverse functions
Olsen et al. Strategies for the inhibition of gingipains for the potential treatment of periodontitis and associated systemic diseases
AU711526B2 (en) Anti-fungal D-amino acid histatin-based peptides
US20140288007A1 (en) Gingipain inhibitory propeptides
WO2014183168A1 (en) Inhibitory propeptides
US20120283174A1 (en) Antibiofilm glycopeptides
Kantyka et al. Elafin is specifically inactivated by RgpB from Porphyromonas gingivalis by distinct proteolytic cleavage
JP4847341B2 (ja) 抗菌性組成物
US20050207995A1 (en) Methods and compositions for promoting oral health, and polypeptides useful for same
WO2010060636A1 (en) Antimicrobial therapy
Class et al. Inventors: Eric Charles Reynolds (Carlton, AU) Eric Charles Reynolds (Carlton, AU) Stuart Geoffrey Dashper (Carlton, AU) Assignees: ORAL HEALTH AUSTRALIA PTY LTD
WO2023182185A1 (ja) ジンジパインに対して親和性及び／又は阻害能を有するペプチド及びその使用
CN119219744A (zh) 抗菌肽及其应用
WO2018195637A1 (pt) Cistatina recombinante da cana-de-açúcar para redução do desgaste dentário erosivo e proteção contra cárie dentária
WO2012113037A1 (en) Method for inhibiting proteins

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20120516